Trioday

Tenofovir Disoproxil Fumarate (TDF) stands as a cornerstone in the treatment of HIV/AIDS, offering a potent and well-established antiretroviral therapy option. As a nucleotide reverse transcriptase inhibitor (NRTI), TDF works by inhibiting the enzyme reverse transcriptase, crucial for the replication of the HIV virus. Its robust antiviral activity is evidenced by its ability to achieve sustained suppression of viral load, thereby slowing disease progression and preserving immune function. Moreover, TDF has demonstrated efficacy across various patient populations and HIV viral subtypes, making it a versatile treatment option for individuals living with HIV.